2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Deckers Outdoor entered into a First Amendment to its credit agreement with Citibank, N.A. as administrative agent, effective August 27, 2026. The amendment increases unsecured revolving commitments to $500 million, extends the maturity to August 27, 2031, and lowers the commitment fee on unused amounts. The filing says proceeds will be used for working capital and general corporate purposes.
Unsecured revolving commitments increased to $500 million
Maturity extended to August 27, 2031, subject to lender extension conditions
Commitment fee on unused amounts now 0.10% to 0.175% per annum, based on total net leverage ratio
Benelux subsidiary Deckers Benelux B.V. released as a borrower
Forum Energy Technologies filed a legal opinion from Gibson, Dunn & Crutcher LLP, issued for a prospectus supplement it filed with the SEC on August 28, 2026 under its Form S-3 registration statement. The filing is administrative and does not state the size, price, or purpose of any offering, so it gives shareholders no new financial results.
Exhibit 5.1 is a Gibson, Dunn & Crutcher LLP opinion tied to a prospectus supplement filed August 28, 2026
The opinion relates to Form S-3 registration statement File No. 333-298624
Exhibit 23.1 is the law firm's consent, included within Exhibit 5.1
Spero Therapeutics entered an at-the-market share sale agreement with Jefferies LLC as agent on August 28, 2026, allowing it to sell common stock up to $100 million once its $300 million universal shelf registration statement is declared effective. The company also terminated its prior Cantor Fitzgerald at-the-market agreement effective the same day, with no termination penalties and no shares sold under that agreement in fiscal 2024 or 2025. Shareholders could face dilution if the company sells shares under the new agreement, but the filing states no amount has been sold and no sales can occur until the registration is effective.
Agreement with Jefferies allows sales of up to $100 million of common stock under the prospectus once the registration statement is effective
Jefferies compensation is up to 3.0% of gross proceeds from shares sold
Shelf registration on Form S-3 covers up to $300 million in debt securities, common stock, preferred stock and other securities
Cantor Fitzgerald sales agreement terminated effective August 28, 2026, with no termination penalties and no shares sold in fiscal 2024 or 2025
On August 26, 2026, RenX Enterprises sold $5,662,716.07 in second senior convertible notes and second warrants in a private placement, with net proceeds of about $5.4 million after fees. The company used the proceeds to repay its February notes at 110% of their outstanding principal, and amended the related agreements to change registration deadlines and liquidated damages terms. The filing shows added debt and potential dilution from conversion and warrant shares, though it does not state a financial result.
Second Notes principal of $5,662,716.07 issued August 26, 2026; net proceeds of about $5.4 million
Up to 11,664,772 shares issuable on conversion at the Floor Price, and 3,520,859 shares under Second Warrants
Proceeds used to repay February Notes at 110% of outstanding principal
Second Registration Statement due 15th calendar day after the Second Closing Date
Coherus Oncology entered an at-the-market sales agreement with Leerink Partners allowing it to sell up to $50.0 million of common stock from time to time, at its discretion. The company is not obligated to sell any shares, and it will pay the agent a commission of up to 3.0% of gross proceeds, so the program could dilute existing holders if used.
Sales Agreement with Leerink Partners LLC dated August 28, 2026, covering up to $50.0 million in common stock
Agent commission of up to 3.0% of gross proceeds from each sale
Shares offered under Form S-3 shelf registration declared effective December 8, 2025
Net proceeds intended for general corporate purposes, including working capital
Katapult Holdings' subsidiary CCF OpCo LLC signed a Sixth Amendment to its revolving credit agreement with lenders led by The Huntington National Bank as administrative agent. The amendment extends the scheduled Draw Period Termination Date from August 30, 2026 to September 30, 2026, giving the borrower an extra month to draw on the facility. The filing does not state the facility size or any change in terms beyond the date.
Draw Period Termination Date extended from August 30, 2026 to September 30, 2026
Early termination is possible upon an unwaived Cease Funding Event, and further extensions require lender approval
After a Draw Period Termination Date, a twelve-month amortization period starts, with maturity deferred to its end absent an Event of Default
Amendment is filed as Exhibit 10.1; signed by CFO Russell Falkenstein
On August 24, 2026, Boeing entered a $3.0 billion 364-day revolving credit agreement with Citibank and JPMorgan, replacing a facility that was due to terminate that day. The company also amended its 2024 and 2023 five-year credit agreements to extend their terms and add a minimum liquidity covenant of $5.0 billion. The filing describes committed borrowing capacity and does not state any amounts drawn.
The new $3.0 billion 364-day facility is scheduled to terminate on August 23, 2027, with fees of 0.125% to 0.300% per annum on commitments depending on Boeing's credit rating.
The 2024 Five-Year Credit Agreement ($4.0 billion in commitments) now terminates May 15, 2030; the 2023 Five-Year Credit Agreement ($3.0 billion) now terminates August 24, 2029.
The agreements add or keep covenants including minimum liquidity of at least $5.0 billion and consolidated debt not exceeding 60% of total capital.
Vroom's subsidiaries UACC and UACC Auto Financing Trust V signed Amendment No. 11 to their Warehouse Credit Facility with Capital One, N.A. as administrative agent. The amendment pushes the Commitment Termination Date from August 28, 2026 to September 30, 2026, and the filing says all other material terms are unchanged.
Amendment No. 11 was entered into on August 26, 2026.
Commitment Termination Date extended from August 28, 2026 to September 30, 2026.
Capital One, N.A. is administrative agent; all other material terms remain unchanged.
Rainier Acquisition Corporation, a special purpose acquisition company focused on global life sciences, closed its initial public offering on August 28, 2026, selling 7,500,000 units at $10.00 per unit for gross proceeds of $75,000,000 before underwriting discounts and offering expenses. The company placed $75,000,000 in a trust account, and the filing states that trust funds generally stay there until a business combination is completed or specified redemption events occur, with a 24-month deadline from the IPO closing to complete a business combination. Shareholders should note that the filing reports the IPO closing and related agreements, not any target business or acquisition agreement.
IPO closed August 28, 2026: 7,500,000 units at $10.00 each, $75,000,000 gross proceeds; units began trading as RNAQU on Nasdaq Capital Market on August 27, 2026
$75,000,000 placed in a trust account maintained by Continental Stock Transfer & Trust Company; the company has 24 months from IPO closing to complete an initial business combination
Sponsor Ravenna 7 LLC agreed to buy 194,375 private placement units at $10.00 each; underwriters hold a 45-day option for up to 1,125,000 additional units
Wing C. Lam, PharmD and Chidozie Ugwumba were appointed to the board on August 26, 2026; Ugwumba chairs the audit committee
Choice Hotels International entered a $500 million unsecured term loan under a credit agreement with Wells Fargo Bank as administrative agent, dated August 28, 2026. The company says proceeds are expected for general corporate purposes, including working capital and debt repayment. The loan adds $500 million of direct debt and comes with covenants limiting dividends and stock repurchases, which may affect shareholder payouts.
$500 million unsecured term loan with scheduled maturity on August 28, 2029, plus an optional one-year extension subject to lender consent
Interest at SOFR (0.00% floor) plus 1.25%, or a base rate plus 0.25%, at the company's election
Financial covenants require a fixed charge coverage ratio of at least 2.5 to 1.0 and a leverage ratio of not more than 4.5 to 1.0, with the fixed charge coverage requirement waived while the company holds an Investment Grade Rating
Agreement restricts dividends and stock repurchases, and the filing lists Wells Fargo Bank, National Association as administrative agent
Pool Corporation subsidiaries signed Amendment No. 14 to their receivables securitization facility on August 25, 2026, extending the facility termination date to August 25, 2028. The maximum limit is $400 million from March through September and $300 million in the remaining months, with borrowings priced at one-month Term SOFR plus 0.75% or 0.85%, depending on tranche.
Termination date extended to August 25, 2028, with the agreement effective August 25, 2026
Maximum facility limit of $400 million (March through September): $300 million committed and $100 million uncommitted
Maximum limit of $300 million ($200 million committed and $100 million uncommitted) in the other months of the year
Interest at one-month Term SOFR plus 0.75% (committed) or 0.85% (uncommitted); Wells Fargo Bank, National Association is administrative agent
OFS Capital Corporation issued notice that it will redeem $20,000,000 of its 7.50% Notes due 2028 on September 29, 2026, at 100% of principal plus accrued interest. Of the $69,000,000 of Notes outstanding, $20,000,000 is being redeemed, leaving the remainder outstanding; the filing describes the redemption as routine and does not report a financial result or change in guidance.
Redemption amount: $20,000,000 aggregate principal of the $69,000,000 Notes outstanding
Redemption date: September 29, 2026; price is 100% of principal plus accrued and unpaid interest
Interest on redeemed Notes stops accruing on the Redemption Date; trustee is U.S. Bank Trust Company, National Association
INVO Fertility furnished an investor presentation for use at the H.C. Wainwright 28th Annual Global Investment Conference, September 14 to 16, 2026, and disclosed that it has sold 2,094,395 shares to Alumni Capital LP under a July 24, 2026 purchase agreement for approximately $3,591,000. Shareholders may note the ongoing share sales, which add to the outstanding share count, under a facility with a commitment amount of up to $15 million that could be increased to $50 million by mutual agreement.
Investor presentation to be used at H.C. Wainwright 28th Annual Global Investment Conference, September 14 to 16, 2026, and posted to the Investors section of the company website on August 28, 2026
Shares sold to Alumni Capital LP since SEC effectiveness: 2,094,395 shares for approximately $3,591,000, at an approximate average of $1.71 per share
Purchase agreement dated July 24, 2026 allows the company to sell up to $15 million in shares, with an option to increase to $50 million by mutual written agreement
Pluri Inc. agreed on August 26, 2026, to sell 1,200,000 common shares and pre-funded warrants for up to 1,028,940 shares in a registered direct offering, with a concurrent private placement of common warrants for 2,228,940 shares. The offering is expected to close on August 28, 2026, with estimated net proceeds of about $2,984,808 for corporate development, general purposes and working capital. The sale adds shares and warrant exercise rights that could dilute existing shareholders.
Shares priced at $1.50 each; pre-funded warrants priced at $1.49999 with a $0.00001 exercise price
Common warrants exercisable at $1.65 per share, initially six months after issuance, for five years
Placement agent A.G.P./Alliance Global Partners receives a 6.50% cash fee on gross proceeds
Directors and executive officers and the company face 45-day restrictions on new share issuances and sales
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.